Clinical trial
A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes
NCT00357370 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00357370 |
|---|---|
| Title | A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes |
| Official title | A Pilot Study of the Efficacy and Safety of BMS-512148 on Glycemic Control in Subjects With Type 2 Diabetes Treated Aggressively But Not Controlled on Combination Antihyperglycemic Therapy With Metformin and/or Thiazolidinedione (TZD) and Insulin. |
| Lead sponsor | AstraZeneca, Industry |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | Dapagliflozin, Placebo |
| Enrollment | 163 |
| Start date | Oct 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Jul 27, 2006 |
| Last update posted | May 11, 2017 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: